Table 3 Between group differences in non-secluded patients
Nr 1 favoured product | Top 3 favoured products | |||||
|---|---|---|---|---|---|---|
Psychiatrist (n = 71) | Emergency physician (n = 37) | Fisher’s exact p | Psychiatrist (n = 71) | Emergency physician (n = 37) | Fisher’s exact p | |
Alprazolam LA | 0 (0) | 0 (0) | – | 1 (1.4) | 0 (0) | – |
Alprazolam | 1 (1.4) | 1 (2.7) | 1.000 | 4 (5.6) | 3 (8.1) | 0.689 |
Aripiprazole | 3 (4.2) | 0 (0) | 0.55 | 7 (9.9) | 0 (0) | 0.093 |
Bromazepam | 0 (0) | 0 (0) | – | 1 (1.4) | 0 (0) | – |
Clonazepam | 0 (0) | 0 (0) | – | 0 (0) | 1 (2.7) | – |
Clorazepaat | 2 (2.8) | 2 (5.4) | 0.605 | 9 (12.7) | 7 (18.9) | 0.404 |
Clotiapine | 17 (23.9) | 4 (10.8) | 0.128 | 28 (39.4) | 15 (40.5) | 1.000 |
Diazepam | 0 (0) | 5 (13.5) | 0.004 | 3 (4.2) | 17 (45.9) | <0.001 |
Droperidol | 5 (7.0) | 2 (5.4) | 1.000 | 17 (23.9) | 11 (29.7) | 0.644 |
Escitalopram | 0 (0) | 0 (0) | – | 0 (0) | 2 (5.4) | 0.115 |
Haloperidol | 3 (4.2) | 4 (10.8) | 0.228 | 6 (8.5) | 14 (37.8) | <0.001 |
Lorazepam | 14 (19.7) | 9 (24.3) | 0.625 | 43 (60.6) | 15 (40.5) | 0.067 |
Midazolam | 0 (0) | 2 (5.4) | 0.115 | 0 (0) | 6 (16.2) | 0.001 |
Olanzapine | 17 (23.9) | 7 (18.9) | 0.631 | 40 (56.3) | 15 (40.5) | 0.156 |
Paliperidone | 0 (0) | 0 (0) | – | 1 (1.4) | 0 (0) | – |
Pipamperone | 0 (0) | 0 (0) | – | 3 (4.2) | 1 (2.7) | 1.000 |
Prazepam | 0 (0) | 0 (0) | – | 1 (1.4) | 0 (0) | – |
Promethiazine | 0 (0) | 0 (0) | – | 0 (0) | 1 (2.7) | – |
Quetiapine | 5 (7.0) | 0 (0) | 0.163 | 22 (31) | 0 (0) | <0.001 |
Risperidone | 2 (2.8) | 0 (0) | 0.545 | 6 (8.5) | 1 (2.7) | 0.418 |
Trazodone | 0 (0) | 0 (0) | – | 1 (1.4) | 0 (0) | – |
Sodium Valproate | 0 (0) | 1 (2.7) | – | 4 (5.6) | 1 (2.7) | 0.659 |
Zuclopenthixol | 0 (0) | 0 (0) | – | 2 (2.8) | 1 (2.7) | 1.000 |
Zuclopenthixol LA | 2 (2.8) | 0 (0) | 0.545 | 14 (19.7) | 0 (0) | 0.002 |